行情

ARDX

ARDX

Ardelyx
NASDAQ

实时行情|Nasdaq Last Sale

7.05
+0.04
+0.57%
已收盘, 16:00 07/08 EDT
开盘
6.97
昨收
7.01
最高
7.05
最低
6.75
成交量
61.02万
成交额
--
52周最高
8.82
52周最低
2.100
市值
6.28亿
市盈率(TTM)
-5.3571
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ARDX价格均价为13.00,最高价位15.00,最低价为11.00。

EPS

ARDX 新闻

更多
Ardelyx (ARDX) Upgraded to Buy: What Does It Mean for the Stock?
Ardelyx (ARDX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 19小时前
Ardelyx files U.S. application for tenapanor
Seeking Alpha - Article · 06/30 14:08
Ardelyx Announces Submission of New Drug Application to the U.S. FDA for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
PR Newswire · 06/30 13:00
Ardelyx Submits New Drug Application To FDA For Tenapanor For Control Of Serum Phosphorus In Adult Patients With CKD On Dialysis
FREMONT, Calif., June 30, 2020 /PRNewswire/ --Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with kidney and
Benzinga · 06/30 12:04
Insider Weekends: Harold Hamm Buys More Of Continental Resources
Seeking Alpha - Article · 06/29 06:03
Independent Chairman David Mott Just Bought 133% More Shares In Ardelyx, Inc. (NASDAQ:ARDX)
Simply Wall St. · 06/28 13:30
Hedge Funds Are Dumping Ardelyx Inc (ARDX)
In this article we will take a look at whether hedge funds think Ardelyx Inc (NASDAQ:ARDX) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Iv
Insider Monkey · 06/19 16:45
Ardelyx's tenapanor lowers serum phosphorus in long-term extension study
Seeking Alpha - Article · 06/15 14:42

所属板块

生物技术和医学研究
+1.13%
制药与医学研究
+0.50%

热门股票

代码
价格
涨跌幅

ARDX 简况

Ardelyx, Inc.是一家临床阶段的生物制药公司,专注于发现、开发和销售用于胃肠(GI)道治疗胃肠和心肾疾病的微创系统治疗药物。该公司主要从事研究、开发和销售生物制药产品业务。它已经发现并设计其主导候选产品,tenapanor。tenapanor是一种局部作用于胃肠道,用于抑制钠转运体钠/氢交换因子3(NHE3)并减少肠内钠和磷摄取的最小系统性小分子。它正于便秘型肠易激综合征(IBS-C)患者的两项关键III期临床研究中评估tenapanor。它正在开发用于治疗高钾血症的RDX022。RDX022是口服非吸收钾粘合剂。其开发项目还包括RDX009项目、RDX013项目和RDX011项目。
展开

微牛提供Ardelyx Inc(NASDAQ-ARDX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ARDX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ARDX股票基本功能。